Figure 2From: Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis Forest plot-analysis of the 48-week biochemical response of entecavir therapy versus adefovir therapy Back to article page